Stock listing
NASDAQ:BBIO BridgeBio Pharma, Inc. Stock
Home listing (NASDAQ) of BridgeBio Pharma, Inc.
Follow BridgeBio Pharma, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:BBIO
$75.00 USD +0.05 (+0.1%)
Close on Nov 2, 2026
- Day range
- $74.20 – $76.70 USDNov 2, 2026
- Volume
- 3.10M sharesNov 2, 2026
- Market cap
- $14.66B USDAt the close on Nov 2, 2026 · price × 195.5M shares outstanding
- 52-week range
- $60.22 – $93.42 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $186.1M USDMedian day 2.42M shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:BBIO · Home | $75.00 USD | +0.045 (+0.1%) | 3,095,469 | $75.01 | $76.70 | $74.20 | $74.95 | Close on Nov 2, 2026 |
| Frankfurt:2CL | €65.62 EUR | +4.70 (+7.7%) | — | €62.06 | €65.62 | €62.06 | €60.92 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:BBIO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $75.00 | +0.045 | +0.1% | $75.01 | $76.70 | $74.20 | 3,095,469 | |
| $74.95 | +4.22 | +6.0% | $72.85 | $75.65 | $71.91 | 5,770,977 | |
| $70.73 | -0.09 | -0.1% | $71.37 | $73.02 | $70.21 | 4,933,383 | |
| $70.82 | +1.45 | +2.1% | $68.79 | $71.18 | $68.65 | 3,111,389 | |
| $69.37 | +1.22 | +1.8% | $68.25 | $69.64 | $68.00 | 2,041,947 | |
| $68.15 | -0.41 | -0.6% | $68.56 | $68.82 | $67.89 | 2,059,129 | |
| $68.56 | +0.44 | +0.6% | $67.69 | $68.86 | $67.02 | 2,403,443 | |
| $68.12 | +0.38 | +0.6% | $67.48 | $69.32 | $67.07 | 2,780,421 | |
| $67.74 | +0.19 | +0.3% | $68.04 | $68.79 | $67.55 | 3,008,801 | |
| $67.55 | -0.39 | -0.6% | $68.28 | $69.00 | $67.25 | 2,732,829 | |
| $67.94 | +1.55 | +2.3% | $67.35 | $68.52 | $66.73 | 2,292,327 | |
| $66.39 | -0.74 | -1.1% | $67.03 | $67.04 | $65.26 | 2,055,500 | |
| $67.13 | +2.19 | +3.4% | $65.67 | $67.76 | $65.44 | 2,638,800 | |
| $64.94 | +1.64 | +2.6% | $63.34 | $65.36 | $62.86 | 2,700,500 | |
| $63.30 | -2.45 | -3.7% | $66.05 | $66.05 | $62.94 | 2,709,000 | |
| $65.75 | +0.40 | +0.6% | $65.35 | $66.42 | $65.20 | 1,778,900 | |
| $65.35 | +0.31 | +0.5% | $65.04 | $65.94 | $64.34 | 1,846,500 | |
| $65.04 | -1.46 | -2.2% | $66.39 | $66.41 | $63.70 | 3,362,000 | |
| $66.50 | -0.46 | -0.7% | $66.78 | $67.59 | $66.15 | 2,064,400 | |
| $66.96 | +0.82 | +1.2% | $67.75 | $68.12 | $65.71 | 3,709,900 | |
| $66.14 | -1.11 | -1.7% | $67.40 | $68.08 | $65.46 | 2,168,500 | |
| $67.25 | +0.34 | +0.5% | $67.10 | $68.68 | $66.23 | 2,646,100 | |
| $66.91 | +1.11 | +1.7% | $65.72 | $67.26 | $65.16 | 3,549,900 | |
| $65.80 | -0.17 | -0.3% | $66.14 | $67.32 | $65.61 | 2,822,400 | |
| $65.97 | -0.64 | -1.0% | $66.38 | $67.16 | $65.82 | 3,596,900 | |
| $66.61 | +1.04 | +1.6% | $65.07 | $67.34 | $64.36 | 2,969,300 | |
| $65.57 | -0.71 | -1.1% | $66.50 | $67.07 | $64.84 | 2,090,200 | |
| $66.28 | +0.57 | +0.9% | $65.85 | $67.30 | $65.33 | 4,271,600 | |
| $65.71 | -3.52 | -5.1% | $69.23 | $70.00 | $64.90 | 3,677,600 | |
| $69.23 | +2.65 | +4.0% | $66.90 | $69.77 | $66.61 | 3,782,400 | |
| $66.58 | -0.03 | 0.0% | $67.01 | $67.33 | $65.78 | 3,167,400 | |
| $66.61 | -0.70 | -1.0% | $67.39 | $67.56 | $66.10 | 4,103,500 | |
| $67.31 | -0.99 | -1.4% | $69.72 | $69.99 | $66.93 | 2,344,100 | |
| $68.30 | -0.09 | -0.1% | $68.52 | $69.46 | $67.11 | 4,785,800 | |
| $68.39 | -3.99 | -5.5% | $72.26 | $72.41 | $66.96 | 3,993,000 | |
| $72.38 | -0.06 | -0.1% | $72.55 | $73.67 | $72.17 | 1,851,300 | |
| $72.44 | -0.06 | -0.1% | $73.23 | $74.11 | $71.98 | 1,766,600 | |
| $72.50 | -3.58 | -4.7% | $75.27 | $75.50 | $72.12 | 3,064,100 | |
| $76.08 | +1.32 | +1.8% | $73.63 | $76.81 | $73.47 | 2,307,000 | |
| $74.76 | -0.08 | -0.1% | $73.60 | $76.34 | $73.26 | 2,094,500 | |
| $74.84 | -0.57 | -0.8% | $74.98 | $75.37 | $74.11 | 1,539,400 | |
| $75.41 | -1.09 | -1.4% | $76.43 | $76.64 | $75.20 | 1,098,000 | |
| $76.50 | -0.07 | -0.1% | $76.60 | $78.25 | $75.96 | 1,620,600 | |
| $76.57 | -0.02 | 0.0% | $76.61 | $77.45 | $76.22 | 1,448,500 | |
| $76.59 | -0.01 | 0.0% | $76.20 | $77.24 | $75.02 | 2,063,600 | |
| $76.60 | -2.08 | -2.6% | $79.99 | $80.55 | $76.34 | 1,922,100 | |
| $78.68 | -0.69 | -0.9% | $79.25 | $79.73 | $78.34 | 1,033,800 | |
| $79.37 | -1.03 | -1.3% | $79.75 | $80.76 | $79.33 | 1,705,000 | |
| $80.40 | -0.67 | -0.8% | $81.89 | $82.50 | $80.20 | 1,469,328 | |
| $81.07 | -0.43 | -0.5% | $80.98 | $81.68 | $80.16 | 1,113,409 | |
| $81.50 | -1.44 | -1.7% | $82.89 | $83.37 | $81.36 | 1,743,900 | |
| $82.94 | -1.01 | -1.2% | $83.51 | $84.37 | $82.63 | 2,030,600 | |
| $83.95 | +0.97 | +1.2% | $84.22 | $85.65 | $83.25 | 3,285,100 | |
| $82.98 | +3.09 | +3.9% | $80.54 | $83.95 | $80.10 | 2,718,300 | |
| $79.89 | +0.03 | 0.0% | $79.15 | $80.42 | $78.13 | 2,795,700 | |
| $79.86 | -1.35 | -1.7% | $80.14 | $80.56 | $78.60 | 3,094,000 | |
| $81.21 | -2.63 | -3.1% | $84.77 | $84.77 | $80.78 | 1,279,700 | |
| $83.84 | +0.14 | +0.2% | $83.47 | $84.99 | $82.82 | 2,793,600 | |
| $83.70 | -0.97 | -1.1% | $87.02 | $89.49 | $83.35 | 3,082,000 | |
| $84.67 | +0.19 | +0.2% | $83.45 | $86.00 | $83.45 | 2,942,600 | |
| $84.48 | +1.68 | +2.0% | $83.72 | $85.03 | $82.24 | 2,148,200 | |
| $82.80 | +0.81 | +1.0% | $81.50 | $84.66 | $81.50 | 1,221,400 | |
| $81.99 | -0.08 | -0.1% | $82.86 | $83.57 | $81.46 | 2,424,400 | |
| $82.07 | +2.11 | +2.6% | $80.80 | $82.32 | $80.04 | 1,703,000 | |
| $79.96 | -0.13 | -0.2% | $81.23 | $81.23 | $78.82 | 1,366,900 |
- Ticker
- NASDAQ:BBIO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 3, 2026
BridgeBio to Present New Acoramidis Data on Heart Failure Events in ATTR-CM at the American Heart Association Scientific Sessions 2026
Latest earnings call · Oct 29, 2026
Bridgebio Pharma (NASDAQ:BBIO) Q3 2026 Earnings Call
Replay and transcript
Latest deck · May 7, 2026
Q1 2026 Earnings Presentation
Earnings · 41 slides
Calls
Replays
Bridgebio Pharma (NASDAQ:BBIO) Q3 2026 Earnings Call
Thu, Oct 29, 2026 · 4:30 PM ET
Watch TranscriptBridgebio Pharma (NASDAQ:BBIO) Q2 2026 Earnings Call
Mon, Aug 10, 2026 · 4:30 PM ET
Watch TranscriptBridgeBio Pharma, Inc. (BBIO) Q1 2026 Earnings Call
Thu, May 07, 2026 · 4:30 PM ET
Watch Transcript
Latest news
BridgeBio Reports Third Quarter 2026 Financial Results and Corporate Updates
Oct 29, 2026
Closed $74.95 (+6.0%) on Oct 30, 2026
BridgeBio to Report Third Quarter 2026 Financial Results and Commercial Updates on October 29, 2026 at 4: 30 pm ET
Oct 22, 2026
Closed $68.12 (+0.6%) on Oct 22, 2026
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Oct 16, 2026
Closed $66.39 (-1.1%) on Oct 16, 2026
BridgeBio to Present New Acoramidis Data, Including Independent Comparative Real-World EHR Data at the HFSA Annual Scientific Meeting 2026
Oct 6, 2026
Closed $66.50 (-0.7%) on Oct 7, 2026
BridgeBio to Present Additional Evidence from the Phase 3 CALIBRATE Trial of Encaleret in ADH1 at the ASBMR 2026 Annual Meeting
Oct 6, 2026
Closed $66.50 (-0.7%) on Oct 7, 2026
BridgeBio and Community Partners Launch Nationwide ATTR-CM Education Effort Ahead of World Amyloidosis Day
Oct 6, 2026
Closed $66.96 (+1.2%) on Oct 6, 2026
BridgeBio Announces FDA Acceptance and Priority Review of NDA for Oral Infigratinib for Children with Achondroplasia
Oct 6, 2026
Closed $66.96 (+1.2%) on Oct 6, 2026
BBP-418 Demonstrates Potential to Be Disease Modifying Therapy, Restoring Cardiac and Disease Markers to Unaffected Levels
Oct 5, 2026
Closed $66.14 (-1.7%) on Oct 5, 2026
BBIO-Infigratinib-ESPE 2026-Longer Term Results
Sep 9, 2026
Closed $76.08 (+1.8%) on Sep 9, 2026
Financings
Preferred equity
Aug 10, 2026
Closed: US$1B raised
Buyers: Sixth Street (led the financing); HealthCare Royalty
Use of proceeds: Fund three potential upcoming launches while continuing to invest in indication expansion across the pipeline
Decks
Q1 2026 Earnings Presentation
Earnings · 41 slides · May 7, 2026
Investor Presentation (February 2026)
Investor deck · 92 slides · Feb 24, 2026
Q4 2025 Earnings Presentation
Earnings · 93 slides · Feb 24, 2026
Technical Presentation (February 2026)
Technical · 32 slides · Feb 12, 2026
BridgeBio Pharma, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 54 in the last 12 months · 270 in all · newest Nov 3, 2026 · oldest 2019
- Calls
- 7 calls with a replay · 7 with a transcript · latest Oct 29, 2026
- Decks
- 29 decks · latest May 7, 2026
Where BridgeBio Pharma, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BBIO · Home listing · This page | NASDAQ | United States | USD |
| gettex:2CL | gettex | Germany | EUR |
| LS Exchange:A2PLX7 | LS Exchange | Germany | EUR |
| Tradegate:2CL | Tradegate | Germany | EUR |
| Lang & Schwarz:A2PLX7 | Lang & Schwarz | Germany | EUR |
| BX Swiss:BBIO | BX Swiss | Switzerland | CHF |
| Milan:1BBIO | Milan | Italy | EUR |
| BOATS:BBIO | BOATS | United States | USD |
| Frankfurt:2CL | Frankfurt | Germany | EUR |
| Dusseldorf:2CL | Dusseldorf | Germany | EUR |
| Hamburg:2CL | Hamburg | Germany | EUR |
| Munich:2CL | Munich | Germany | EUR |
| Stuttgart:2CL | Stuttgart | Germany | EUR |
| BMV:BBIO | BMV | Mexico | MXN |
| Hanover:2CL | Hanover | Germany | EUR |
| Xetra:2CL | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about BridgeBio Pharma, Inc.